EDX Medical Group Plc (EDX): Pneumonia test NHS launch
This situation live
EDX EDX Medical Group Plc
3 Aug 2026 · Deployed in Addenbrooke's ICU; regulatory approval pending · −12% until the next step
We are now working to generate real world data for regulators in order to make the VAP test available more widely as soon as possible
3 Sep 2026 · Clinical evaluation underway since mid-May 2026 · −6% since
clinical evaluation as part of regulatory documentation commenced in mid-May 2026, shortly after the year end.
Pneumonia test NHS launch
Clinical evaluation underway since mid-May 2026
Next: complete clinical evaluation for regulatory documentation
Every step · 3
- 19 Dec 2025 development complete, launch planned – The test is planned to be made available to patients by the end of 2025. ↗
- 3 Aug 2026 Deployed in Addenbrooke's ICU; regulatory approval pending – We are now working to generate real world data for regulators in order to make the VAP test available more widely as soon as possible ↗
- 3 Sep 2026 Clinical evaluation underway since mid-May 2026 – clinical evaluation as part of regulatory documentation commenced in mid-May 2026, shortly after the year end. ↗
What is happening
EDX Medical Group Plc: Pneumonia test NHS launch – Clinical evaluation underway since mid-May 2026. ['Clinical evaluation underway since mid-May 2026']
- Announced
- 19 Dec 2025 · development complete, launch planned
- Latest
- 3 Sep 2026 · Clinical evaluation underway since mid-May 2026
- What it changes
- The audited year shows revenue of only £330,000 against £1.2m flagged in April and a £5.7m loss. Commercial progress and the pneumonia test remain the story, but funding need and recognition risk persist.
What comes next
complete clinical evaluation for regulatory documentation.
Briefing Pro
New to EDX Medical Group Plc? Get up to speed in 2 minutes.
What it does, how it got here, what management promised and delivered – written from its own announcements.
Get the EDX briefing →From the company's own announcements. Not investment advice.
Also at EDX Medical Group Plc 1 open
Stake building towards controlPROFESSOR SIR CHRISTOPHER EVANS towards control – 33.08% (from 0%)
EDX Medical Group Plc – company page →